A Route to Carbasugar Analogues - Jonathan Clayden - The ...
A Route to Carbasugar Analogues - Jonathan Clayden - The ... A Route to Carbasugar Analogues - Jonathan Clayden - The ...
Experimental for chapter 2 Synthesis of (4R,5R)-2-((1S,6R)-6-isopropyl-4-methoxy-1-methylcyclohexa-2,4- dienyl)-4,5-diphenyloxazoline (102b) Ph Ph O N i) i-PrLi (1.5 eq), DMPU (6 eq) ii) MeI OMe Ph Ph Ph Ph O N O N 1 6 2 5 3 4 + 1 6 2 5 3 4 OMe OMe 102b 103b General procedure 4 was used employing oxazoline 101b (2.00 g, 6.08 mmol) i-PrLi (18.2 mmol in pentane), DMPU (4.41 cm 3 , 36.4 mmol) and methyl iodide (0.76 cm 3 , 12.1 mmol) quench after 10 min. Flash chromatography (19:1 to 4:1 petrol:EtOAc) yielded starting material (110 mg, 6%), oxazoline 103b (370 mg, 18%) as a clear oil and, after recrystallisation from diethyl ether, diene 102b (1.64 g, 70%) as colourless clear cubes. 102b R f : 0.60 (4:1 petrol:EtOAc); Mpt: 113-117 °C (toluene/hexane), 108-110 °C (Et 2 O); [α] 24 D : –115 (c = 0.5, MeOH); MS m/z (CI+): 388 (100%, MH + ), 389 (29%, (M+1)H + ); HRMS (ESI+) m/z found 388.2270 (MH calcd. 388.2271); Microanalysis: % found (% calc’d for C 26 H 29 NO 2 ) C 80.42, (80.59); H, 7.76 (7.54); N, 3.56 (3.61); IR ν max (film)/cm -1 : 2957 (CH), 1661 (C=N), 1453, 1220, 1087; 1 H-NMR (CDCl 3 , 300 MHz) δ 7.46-7.18 (m, 10H, Ph), 6.43 (d, 1H, J 10.0, H5), 5.74 (dd, 1H, J 10.0, 2.0, H6), 5.22 (d, 1H, J 5.0, HCO), 5.06 (d, 1H, J 5.0, HCN), 4.53 (dd, 1H, J 6.5, 2.0, H3), 3.62 (s, 3H, OMe), 2.59 (ddd, 1H, J 6.5, 3.5, 1.0, H2), 2.08-1.96 (m, 1H, CHMe 2 ), 1.57 (s, 3H, Me), 1.00 (d, 3H, J 6.5, CHMe a Me b ), 0.96 (d, 3H, J 6.5, CHMe a Me b ); 13 C- NMR (CDCl 3 , 125 MHz) δ 171.2 (C=N), 153.1 (C4), 141.9, 140.3 (ipso-Ph), 135.0 (C5), 128.9 (meta-Ph), 128.7 (meta-Ph), 128.3 (para-Ph), 127.6 (para-Ph), 126.7 (ortho-Ph), 125.7 (ortho-Ph), 121.6 (C6), 89.0 (COPh), 88.4 (C3), 78.8 (HCN), 54.2 (OMe), 46.8 (C2), 41.9 (C1), 31.7 (CMe 2 ), 25.8 (CMe), 21.2 (CMe a Me b ), 17.0 (CMe a Me b ). 103b R f : 0.50 (4:1 petrol:EtOAc); [α] D 22 : –44 (c = 1.0, EtOH); MS m/z (CI+): 344 (100%, MH + ), 345 (22%, (M+1)H + ); HRMS (ESI+) m/z found 344.1645 (MH calcd. 344.1645); IR ν max (film)/cm -1 : 2927 (m, C-H), 1637 (C=N), 1605, 1247; 1 H-NMR 199
Experimental for chapter 2 (CDCl 3 , 300 MHz) δ 8.00 (d, 1H, J 8.5, H6), 7.46-7.28 (m, 10H, Ph), 6.86-6.78 (m, 2H, H3, H5), 5.31 (d, 1H, J 7.5, CHO), 5.26 (d, 1H, J 7.5, CHN), 3.86 (s, 3H, OMe), 2.73 (s, 3H, CMe); 13 C-NMR (CDCl 3 , 125 MHz) δ 164.7 (C=N), 161.3 (C4), 142.5 (C2), 141.7 (ipso-Ph), 140.9 (ipso-Ph), 132.0, 128.9, 128.8, 128.3, 127.6, 126.6, 125.7, 119.2, 116.8, 110.9 (Ar), 87.8 (COPh), 79.3 (CNPh), 55.3 (OMe), 22.7 (Me). Synthesis of (4R,5R)-2-((1S,6R)-6-sec-butyl-4-methoxy-1-methylcyclohexa-2,4- dienyl)-4,5-diphenyloxazoline (102b’) Ph Ph Ph Ph Ph Ph O N i) s-BuLi (3 eq), DMPU (6 eq) -78 °C, 10 min ii) MeI O 1 6 5 N 7 2 3 4 8 9 10 11 + O N OMe OMe dr 7:2 OMe 102b' 103b' General procedure 2 was used employing oxazoline 101b (100 mg, 0.30 mmol) s-BuLi (0.90 mmol in hexanes), DMPU (0.22 cm 3 , 36.4 mmol) and methyl iodide (0.1 cm 3 ) quench after 10 min. Flash chromatography (49:1 to 4:1 petrol:EtOAc) yielded starting material (5 mg, 5%) and oxazolines 102b’ and 103b’ (94 mg, 78%, 9:1 mixture) as a clear oil. R f : 0.29 (9:1, petrol:EtOAc); [α] 22 D : –104 (c = 1.0, CHCl 3 ); MS m/z (CI+) 402 (100%, MH + ), 403 (27%, [(M+1)H] + ); HRMS: found 402.2431, MH requires 402.2428; IR ν max (film)/cm⎯¹ 2959 (m), 1661 (C=N), 1452 (m), 1215, 1173 (m), 1086; ¹H-NMR (major compound) (CDCl 3 , 500 MHz) δ 7.42-7.28 (m, 8H, Ph), 7.24-7.20 (m, 2H, Ph), 6.43 (d, 1H, J 10.0, H6), 5.74 (dd, 1H, J 10.0, 2.0, H5), 5.22 (d, 1H, J 8.5, CHOPh), 5.05 (d, 1H, J 8.5, CHNPh), 4.47 (dd, 1H, J 6.5, 2.0, H3), 3.61 (s, 3H, OMe), 2.73- 2.68 (m, 1H, H2), 1.71-1.64 (m, 1H, H9), 1.57 (s, 3H, H7), 1.42-1.32 (m, 1H, H10), 1.28-1.20 (m, 1H, H10’), 0.99 (d, 3H, J 6.5, H8), 0.95-0.90 (m, 3H, H11); ¹³C-NMR (CDCl 3 , 125 MHz) δ 171.2 (C=N), 153.0 (C4), 141.9 (ipso-Ph), 140.4 (ipso-Ph), 135.1 (C5), 128.7, 128.7, 127.6, 126.7, 125.7 (Ph), 121.7 (C6), 89.0, 88.6 (CHOPh, C3), 78.9 (CHNPh), 54.2 (OMe), 44.8 (C2), 41.7 (C1), 39.0 (C9), 27.6 (C10), 25.8 (C7), 14.8, 12.4 (C8, C11). 200
- Page 147 and 148: 4.2 - Carbasugar synthesis Ox* Ox*
- Page 149 and 150: 4.2 - Carbasugar synthesis Ox* Ox*
- Page 151 and 152: 4.2 - Carbasugar synthesis OsO 4 (c
- Page 153 and 154: 4.2 - Carbasugar synthesis taken on
- Page 155 and 156: 4.2 - Carbasugar synthesis As well
- Page 157 and 158: 4.4 - Revised altrose synthesis 4.4
- Page 159 and 160: 4.4 - Revised altrose synthesis suf
- Page 161 and 162: 4.4 - Revised altrose synthesis ind
- Page 163 and 164: 4.5 - Mannose synthesis 4.5 Synthes
- Page 165 and 166: 4.5 - Mannose synthesis It is clear
- Page 167 and 168: 4.5 - Mannose synthesis considering
- Page 169 and 170: 4.5 - Mannose synthesis which would
- Page 171 and 172: 4.5 - Mannose synthesis One clear a
- Page 173 and 174: 4.5 - Mannose synthesis 4.5.2.b Epo
- Page 175 and 176: 4.5 - Mannose synthesis hydrolysis
- Page 177 and 178: 4.5 - Mannose synthesis The second
- Page 179 and 180: 4.6 - Summary 4.6 Summary & Future
- Page 181 and 182: 4.6 - Summary OH CDI, NH 2 OH.HCl,
- Page 183 and 184: 184
- Page 185 and 186: References (37) Rawson, D. J.; Meye
- Page 187 and 188: References (105) Gajewski, J. J.; B
- Page 189 and 190: References (169) McCormick, J. P.;
- Page 191 and 192: References 192
- Page 193 and 194: Experimental section 254nm, dodecam
- Page 195 and 196: Experimental section General Proced
- Page 197: Experimental for chapter 2 Synthesi
- Page 201 and 202: Experimental for chapter 2 3H, OMe
- Page 203 and 204: Experimental for chapter 2 Ph), 139
- Page 205 and 206: Experimental for chapter 2 H4), 5.2
- Page 207 and 208: Experimental for chapter 2 108 R f
- Page 209 and 210: Experimental for chapter 2 Synthesi
- Page 211 and 212: Experimental for chapter 3.1 satura
- Page 213 and 214: Experimental for chapter 3.1 Na 2 S
- Page 215 and 216: Experimental for chapter 3.1 Synthe
- Page 217 and 218: Experimental for chapter 3.1 Synthe
- Page 219 and 220: Experimental for chapter 3.1 128.9,
- Page 221 and 222: Experimental for chapter 3.1 Microw
- Page 223 and 224: Experimental for chapter 3.1 R f :
- Page 225 and 226: Experimental for chapter 3.1 Synthe
- Page 227 and 228: Experimental for chapter 3.1 Synthe
- Page 229 and 230: Experimental for chapter 3.1 Synthe
- Page 231 and 232: Experimental for chapter 3.1 Synthe
- Page 233 and 234: Experimental for chapter 3.1 Synthe
- Page 235 and 236: Experimental for chapter 3.2 Synthe
- Page 237 and 238: Experimental for chapter 3.2 Synthe
- Page 239 and 240: Experimental for chapter 3.2 Synthe
- Page 241 and 242: Experimental for chapter 3.2 Synthe
- Page 243 and 244: Experimental for chapter 3.2 Synthe
- Page 245 and 246: Experimental for chapter 3.2 Synthe
- Page 247 and 248: Experimental for chapter 4.1 281 R
Experimental for chapter 2<br />
(CDCl 3 , 300 MHz) δ 8.00 (d, 1H, J 8.5, H6), 7.46-7.28 (m, 10H, Ph), 6.86-6.78 (m,<br />
2H, H3, H5), 5.31 (d, 1H, J 7.5, CHO), 5.26 (d, 1H, J 7.5, CHN), 3.86 (s, 3H, OMe),<br />
2.73 (s, 3H, CMe); 13 C-NMR (CDCl 3 , 125 MHz) δ 164.7 (C=N), 161.3 (C4), 142.5<br />
(C2), 141.7 (ipso-Ph), 140.9 (ipso-Ph), 132.0, 128.9, 128.8, 128.3, 127.6, 126.6, 125.7,<br />
119.2, 116.8, 110.9 (Ar), 87.8 (COPh), 79.3 (CNPh), 55.3 (OMe), 22.7 (Me).<br />
Synthesis of (4R,5R)-2-((1S,6R)-6-sec-butyl-4-methoxy-1-methylcyclohexa-2,4-<br />
dienyl)-4,5-diphenyloxazoline (102b’)<br />
Ph<br />
Ph<br />
Ph<br />
Ph<br />
Ph<br />
Ph<br />
O<br />
N<br />
i) s-BuLi (3 eq), DMPU (6 eq)<br />
-78 °C, 10 min<br />
ii) MeI<br />
O<br />
1<br />
6<br />
5<br />
N<br />
7<br />
2<br />
3<br />
4<br />
8<br />
9<br />
10<br />
11<br />
+<br />
O<br />
N<br />
OMe<br />
OMe<br />
dr 7:2<br />
OMe<br />
102b'<br />
103b'<br />
General procedure 2 was used employing oxazoline 101b (100 mg, 0.30 mmol) s-BuLi<br />
(0.90 mmol in hexanes), DMPU (0.22 cm 3 , 36.4 mmol) and methyl iodide (0.1 cm 3 )<br />
quench after 10 min. Flash chroma<strong>to</strong>graphy (49:1 <strong>to</strong> 4:1 petrol:EtOAc) yielded<br />
starting material (5 mg, 5%) and oxazolines 102b’ and 103b’ (94 mg, 78%, 9:1<br />
mixture) as a clear oil.<br />
R f : 0.29 (9:1, petrol:EtOAc); [α] 22 D : –104 (c = 1.0, CHCl 3 ); MS m/z (CI+) 402 (100%,<br />
MH + ), 403 (27%, [(M+1)H] + ); HRMS: found 402.2431, MH requires 402.2428; IR<br />
ν max (film)/cm⎯¹ 2959 (m), 1661 (C=N), 1452 (m), 1215, 1173 (m), 1086; ¹H-NMR<br />
(major compound) (CDCl 3 , 500 MHz) δ 7.42-7.28 (m, 8H, Ph), 7.24-7.20 (m, 2H, Ph),<br />
6.43 (d, 1H, J 10.0, H6), 5.74 (dd, 1H, J 10.0, 2.0, H5), 5.22 (d, 1H, J 8.5, CHOPh),<br />
5.05 (d, 1H, J 8.5, CHNPh), 4.47 (dd, 1H, J 6.5, 2.0, H3), 3.61 (s, 3H, OMe), 2.73-<br />
2.68 (m, 1H, H2), 1.71-1.64 (m, 1H, H9), 1.57 (s, 3H, H7), 1.42-1.32 (m, 1H, H10),<br />
1.28-1.20 (m, 1H, H10’), 0.99 (d, 3H, J 6.5, H8), 0.95-0.90 (m, 3H, H11); ¹³C-NMR<br />
(CDCl 3 , 125 MHz) δ 171.2 (C=N), 153.0 (C4), 141.9 (ipso-Ph), 140.4 (ipso-Ph), 135.1<br />
(C5), 128.7, 128.7, 127.6, 126.7, 125.7 (Ph), 121.7 (C6), 89.0, 88.6 (CHOPh, C3), 78.9<br />
(CHNPh), 54.2 (OMe), 44.8 (C2), 41.7 (C1), 39.0 (C9), 27.6 (C10), 25.8 (C7), 14.8,<br />
12.4 (C8, C11).<br />
200